These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 8383421)

  • 21. Distinctive properties of an anaplastic Wilms' tumor and its associated epithelial cell line.
    Hazen-Martin DJ; Re GG; Garvin AJ; Sens DA
    Am J Pathol; 1994 May; 144(5):1023-34. PubMed ID: 8178926
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Production of platelet-derived growth factor by cultured Wilms' tumor cells and fetal kidney cells.
    Fraizer GE; Bowen-Pope DF; Vogel AM
    J Cell Physiol; 1987 Oct; 133(1):169-74. PubMed ID: 2444606
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of E2F3 expression with clinicopathological features of Wilms' tumors.
    An Q; Wang Y; An R; Li Y; Yao T; Zhai B; Sun X
    J Pediatr Surg; 2013 Nov; 48(11):2187-93. PubMed ID: 24210184
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Etiology of Wilms' tumor.
    Sharpe CR; Franco EL
    Epidemiol Rev; 1995; 17(2):415-32. PubMed ID: 8654519
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Imbalanced expression of functionally different WT1 isoforms may contribute to sporadic unilateral Wilms' tumor.
    Liu JJ; Wang ZY; Deuel TF; Xu YH
    Biochem Biophys Res Commun; 1999 Jan; 254(1):197-9. PubMed ID: 9920757
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression and prognostic value of Wilms' tumor 1 and early growth response 1 proteins in nephroblastoma.
    Ghanem MA; Van der Kwast TH; Den Hollander JC; Sudaryo MK; Oomen MH; Noordzij MA; Van den Heuvel MM; Nassef SM; Nijman RM; Van Steenbrugge GJ
    Clin Cancer Res; 2000 Nov; 6(11):4265-71. PubMed ID: 11106242
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of membrane-bound CR1 (CD35) in human urine: evidence for its release by glomerular podocytes.
    Pascual M; Steiger G; Sadallah S; Paccaud JP; Carpentier JL; James R; Schifferli JA
    J Exp Med; 1994 Mar; 179(3):889-99. PubMed ID: 8113681
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Loss of imprinting of IGF2 sense and antisense transcripts in Wilms' tumor.
    Vu TH; Chuyen NV; Li T; Hoffman AR
    Cancer Res; 2003 Apr; 63(8):1900-5. PubMed ID: 12702581
    [TBL] [Abstract][Full Text] [Related]  

  • 29. No complement receptor 1 stumps on podocytes in human glomerulopathies.
    Moll S; Miot S; Sadallah S; Gudat F; Mihatsch MJ; Schifferli JA
    Kidney Int; 2001 Jan; 59(1):160-8. PubMed ID: 11135068
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of CCN3 protein in human Wilms' tumors: immunohistochemical detection of CCN3 variants using domain-specific antibodies.
    Subramaniam MM; Lazar N; Navarro S; Perbal B; Llombart-Bosch A
    Virchows Arch; 2008 Jan; 452(1):33-9. PubMed ID: 18066593
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of the human glomerular C3 receptor as the C3b/C4b complement type one (CR1) receptor.
    Fischer E; Appay MD; Cook J; Kazatchkine MD
    J Immunol; 1986 Feb; 136(4):1373-7. PubMed ID: 2418113
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Deficient expression of mRNA for the putative inductive factor bone morphogenetic protein-7 in chemically initiated rat nephroblastomas.
    Higinbotham KG; Karavanova ID; Diwan BA; Perantoni AO
    Mol Carcinog; 1998 Oct; 23(2):53-61. PubMed ID: 9808158
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential expression of the lung resistance-related protein/major vault protein in the histological compartments of nephroblastomas.
    Efferth T; Bode ME; Schulten HG; Thelen P; Granzen B; Beniers AJ; Mertens R; Gefeller O; Ringert RH; Jakse G; Fuzesi L
    Int J Oncol; 2001 Jul; 19(1):163-8. PubMed ID: 11408938
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular characterization of rat glomerular epithelial cell complement receptors.
    Quigg RJ; Sneed AE
    J Am Soc Nephrol; 1994 May; 4(11):1912-9. PubMed ID: 7919144
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Nephroblastomas (Wilms' tumors) and special variations of nephroblastomas].
    Schmidt D
    Veroff Pathol; 1989; 133():1-174. PubMed ID: 2556868
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Correlation of chromosome abnormalities with histological and clinical features in Wilms' and other childhood renal tumors.
    Kaneko Y; Homma C; Maseki N; Sakurai M; Hata J
    Cancer Res; 1991 Nov; 51(21):5937-42. PubMed ID: 1657374
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Presence of the C3b complement receptor (CR1) antigen in the glomerular basement membrane of human fetal kidneys.
    Appay MD; Kazatchkine MD; Mounier F; Bariety J
    Nephrol Dial Transplant; 1988; 3(2):162-5. PubMed ID: 2971899
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Insulin-like growth factor II messenger ribonucleic acid expression in Wilms tumor, nephrogenic rest, and kidney.
    Yun K; Molenaar AJ; Fiedler AM; Mark AJ; Eccles MR; Becroft DM; Reeve AE
    Lab Invest; 1993 Nov; 69(5):603-15. PubMed ID: 7504120
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of a monoclonal antibody recognizing the blastemal element of Wilms' tumors and fetal kidneys.
    Tarnowski BI; Hazen-Martin DJ; Garvin AJ; Sens MA; Sens DA
    Pediatr Pathol; 1994; 14(5):849-62. PubMed ID: 7808983
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The significance of VEGF-C/VEGFR-2 interaction in the neovascularization and prognosis of nephroblastoma (Wilms' tumour).
    Nowicki M; Ostalska-Nowicka D; Kaczmarek M; Miskowiak B; Witt M
    Histopathology; 2007 Feb; 50(3):358-64. PubMed ID: 17257131
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.